AP NEWS
ADVERTISEMENT
Press release content from PR Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

Evommune to Present at the 20th Annual Needham Virtual Healthcare Conference

April 12, 2021 GMT
(PRNewsfoto/Evommune, Inc.)
(PRNewsfoto/Evommune, Inc.)

LOS ALTOS, Calif., April 12, 2021 /PRNewswire/ -- Evommune, Inc., a private R&D company and innovation engine in chronic inflammation, today announced that Luis Peña, president and chief executive officer, will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021, at 11:15 a.m. PDT/2:15 p.m. EDT.

To access the live webcast and to watch the replay following the presentation, please click here.

ADVERTISEMENT

About Evommune, Inc.
Evommune is a private R&D company and innovation engine in chronic inflammation. The company is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases. Evommune was founded in 2020 by a successful and experienced leadership team focused on building a robust pipeline of unique therapies that help patients with chronic inflammatory diseases. The company is headquartered in Los Altos, Calif. For more information, please visit Evommune.com.

Media & Investor Contact:
Sheryl Seapy
949-903-4750
sseapy@realchemistry.com

View original content to download multimedia: http://www.prnewswire.com/news-releases/evommune-to-present-at-the-20th-annual-needham-virtual-healthcare-conference-301266053.html

SOURCE Evommune, Inc.